C-Rad Past Earnings Performance
Past criteria checks 5/6
C-Rad has been growing earnings at an average annual rate of 43.1%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 19.7% per year. C-Rad's return on equity is 18.7%, and it has net margins of 11.9%.
Key information
43.1%
Earnings growth rate
42.2%
EPS growth rate
Medical Equipment Industry Growth | 6.2% |
Revenue growth rate | 19.7% |
Return on equity | 18.7% |
Net Margin | 11.9% |
Next Earnings Update | 07 Feb 2025 |
Recent past performance updates
Recent updates
Sentiment Still Eluding C-Rad AB (publ) (STO:CRAD B)
Oct 24Market Participants Recognise C-Rad AB (publ)'s (STO:CRAD B) Earnings Pushing Shares 29% Higher
Jun 02Returns On Capital Are A Standout For C-Rad (STO:CRAD B)
Mar 01C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem
Feb 15Do C-Rad's (STO:CRAD B) Earnings Warrant Your Attention?
Feb 03C-Rad AB (publ)'s (STO:CRAD B) Popularity With Investors Is Clear
Jan 19Is Now The Time To Look At Buying C-Rad AB (publ) (STO:CRAD B)?
Oct 28Returns Are Gaining Momentum At C-Rad (STO:CRAD B)
Aug 16Are Investors Undervaluing C-Rad AB (publ) (STO:CRAD B) By 45%?
Dec 14Is Now An Opportune Moment To Examine C-Rad AB (publ) (STO:CRAD B)?
Jul 20Returns Are Gaining Momentum At C-Rad (STO:CRAD B)
May 07Earnings Miss: C-Rad AB (publ) Missed EPS By 5.5% And Analysts Are Revising Their Forecasts
Jan 30C-Rad (STO:CRAD B) Shareholders Will Want The ROCE Trajectory To Continue
Jul 03Will the Promising Trends At C-Rad (STO:CRAD B) Continue?
Mar 05Are C-Rad's (STO:CRAD B) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 07What Percentage Of C-Rad AB (publ) (STO:CRAD B) Shares Do Insiders Own?
Jan 17Revenue & Expenses Breakdown
How C-Rad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 486 | 58 | 259 | 0 |
30 Jun 24 | 497 | 54 | 257 | 0 |
31 Mar 24 | 458 | 48 | 242 | 0 |
31 Dec 23 | 425 | 36 | 229 | 0 |
30 Sep 23 | 385 | 24 | 216 | 0 |
30 Jun 23 | 357 | 20 | 205 | 0 |
31 Mar 23 | 329 | 12 | 195 | 0 |
31 Dec 22 | 301 | 7 | 179 | 0 |
30 Sep 22 | 280 | 14 | 154 | 0 |
30 Jun 22 | 260 | 12 | 143 | 0 |
31 Mar 22 | 257 | 21 | 131 | 0 |
31 Dec 21 | 261 | 25 | 124 | 0 |
30 Sep 21 | 258 | 26 | 120 | 0 |
30 Jun 21 | 247 | 25 | 114 | 0 |
31 Mar 21 | 230 | 17 | 110 | 0 |
31 Dec 20 | 222 | 14 | 109 | 0 |
30 Sep 20 | 198 | -11 | 110 | 0 |
30 Jun 20 | 201 | -16 | 115 | 0 |
31 Mar 20 | 210 | -14 | 120 | 0 |
31 Dec 19 | 205 | -14 | 117 | 0 |
30 Sep 19 | 212 | 23 | 114 | 0 |
30 Jun 19 | 203 | 24 | 111 | 0 |
31 Mar 19 | 204 | 27 | 106 | 0 |
31 Dec 18 | 190 | 21 | 105 | 0 |
30 Sep 18 | 174 | -2 | 101 | 0 |
30 Jun 18 | 161 | -4 | 94 | 0 |
31 Mar 18 | 141 | -10 | 91 | 0 |
31 Dec 17 | 133 | -11 | 88 | 0 |
30 Sep 17 | 118 | -16 | 84 | 0 |
30 Jun 17 | 108 | -23 | 83 | 0 |
31 Mar 17 | 90 | -28 | 80 | 0 |
31 Dec 16 | 83 | -31 | 75 | 0 |
30 Sep 16 | 74 | -33 | 71 | 0 |
30 Jun 16 | 70 | -32 | 67 | 0 |
31 Mar 16 | 73 | -27 | 62 | 0 |
31 Dec 15 | 73 | -21 | 58 | 0 |
30 Sep 15 | 73 | -20 | 57 | 0 |
30 Jun 15 | 66 | -16 | 52 | 0 |
31 Mar 15 | 62 | -8 | 50 | 0 |
31 Dec 14 | 57 | -7 | 47 | 0 |
30 Sep 14 | 56 | -5 | 45 | 0 |
30 Jun 14 | 59 | -4 | 44 | 0 |
31 Mar 14 | 52 | -17 | 44 | 0 |
31 Dec 13 | 49 | -21 | 44 | 0 |
Quality Earnings: CRAD B has high quality earnings.
Growing Profit Margin: CRAD B's current net profit margins (11.9%) are higher than last year (6.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CRAD B's earnings have grown significantly by 43.1% per year over the past 5 years.
Accelerating Growth: CRAD B's earnings growth over the past year (140.6%) exceeds its 5-year average (43.1% per year).
Earnings vs Industry: CRAD B earnings growth over the past year (140.6%) exceeded the Medical Equipment industry 31%.
Return on Equity
High ROE: CRAD B's Return on Equity (18.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 17:50 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
C-Rad AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Victor Forssell | ABG Sundal Collier Sponsored |
Christian Lee | Pareto Securities |